|
TMCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91839999996724E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.281200E-03 |
| Normal-vs-Stage2 |
1.604760E-03 |
| Normal-vs-Stage3 |
3.378000E-02 |
| Normal-vs-Stage4 |
6.018300E-02 |
| Stage1-vs-Stage2 |
1.523660E-02 |
| Stage1-vs-Stage3 |
2.167000E-01 |
| Stage1-vs-Stage4 |
1.123250E-01 |
| Stage2-vs-Stage3 |
6.654000E-01 |
| Stage2-vs-Stage4 |
8.689800E-01 |
| Stage3-vs-Stage4 |
8.593600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.37420000001498E-06 |
| Normal-vs-AfricanAmerican |
7.086500E-02 |
| Normal-vs-Asian |
2.161400E-01 |
| Caucasian-vs-AfricanAmerican |
2.501600E-03 |
| Caucasian-vs-Asian |
1.528400E-01 |
| AfricanAmerican-vs-Asian |
8.951200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.763510E-04 |
| Normal-vs-Female |
9.07340000022572E-07 |
| Male-vs-Female |
9.841800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.916500E-02 |
| Normal-vs-Extreme_Weight |
4.469900E-02 |
| Normal-vs-Obese |
2.563900E-03 |
| Normal-vs-Extreme_Obese |
1.087400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.648800E-01 |
| Normal_Weight-vs-Obese |
9.886200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.455200E-01 |
| Extreme_Weight-vs-Obese |
2.108400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.355000E-01 |
| Obese-vs-Extreme_Obese |
7.907200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.326400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.69300999999233E-05 |
| Normal-vs-Age(61-80Yrs) |
1.437870E-03 |
| Normal-vs-Age(81-100Yrs) |
8.968000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.290200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.730200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.110160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.828100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.061900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.989000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.354040E-04 |
| Normal-VS-Type2 PRCC |
3.364600E-03 |
| Normal-VS-KIRP CIMP |
1.311580E-02 |
| Normal-VS-Unclassified PRCC |
3.764400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.495200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.023900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.604800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.458000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.518400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.843500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.630420E-02 |
| Normal-vs-N1 |
4.338500E-03 |
| Normal-vs-N2 |
3.300200E-01 |
| N0-vs-N1 |
2.553200E-01 |
| N0-vs-N2 |
8.669800E-01 |
| N1-vs-N2 |
7.093400E-01 |
|
|
